FIELD: medicine.
SUBSTANCE: invention refers to biotechnology and medicine. What is presented is a method for differentiating pluripotent stem cell population recovered from recognised pluripotent stem cell lines into a cell population expressing markers specific for a pancreatic entoderm line co-expressing PDX1, NKX6.1, but not expressing CDX2 and NGN3.
EFFECT: method can be used for medical and biotechnological applications.
9 dwg, 2 tbl, 4 ex
Authors
Dates
2015-01-27—Published
2010-07-19—Filed